Oral Biopsies: Evaluation of the Post-surgical Discomfort

August 13, 2020 updated by: Carlo Lajolo, Catholic University of the Sacred Heart

Evaluation of the Post-surgical Discomfort in Patients Undergoing Diagnostic Oral Biopsies

Aim of this study is to evaluate the post-operative course in patients undergoing diagnostic or therapeutic oral mucosal biopsies.

To evaluate the wound healing, all variables connected with the surgery (including post-operative complications) were recorded. To evaluate the psychological and behavioral impact of the post-operative discomfort, two survey tools were administered: OHIP-14 and visual number scale of pain (VNS) were administered at 6h, 7 days and 21 days after biopsy.

Study Overview

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy, 00168
        • Catholic University of the Sacred Heart

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Eighty-four patients were enrolled in this study; four of them were excluded because the clinical records were incomplete. Among the 80 patients left, 30 were males and 50 females, with a mean age of 60.25 years (range 23-88); clinical data about remote pathological history were collected: 31/80 patients did not have any systemic diseases, 22/80 only one disease, 27/80 more than one disease; 36/80 patients did not take any drug, 16/80 only one and 28/80 more than one; 63/80 patients did not smoke, 10/80 were former smokers and 7/80 were smokers.

Description

Inclusion Criteria:

  • no systemic or local contraindications for surgical treatment
  • need for an oral biopsy (both excisional and incisional).

Exclusion Criteria:

Since no absolute contraindications to oral biopsies are reported, no exclusion criteria were selected for this study, but if any relative contraindication was present (i.e. bleeding disorders) biopsy was performed after the resolution of the problem

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Oral Biopsy
Patients with oral lesions undergoing diagnostic or therapeutic biopsies either for benign lesions or potentially malignant disorders or malignant lesions or salivary glands diseases.
All patients fulfilled the OHIP-14 questionnaire three times: six hours, seven days and twenty-one days after the biopsy
All patients fulfilled the VNS scale three times: six hours, seven days and twenty-one days after the biopsy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between the clinical healing and patient perception
Time Frame: Six hours after an oral biopsy
To evaluate whether the clinical evaluation of a wound healing shows a correspondence with the patient perception of the same process.
Six hours after an oral biopsy
Correlation between the clinical healing and patient perception
Time Frame: One week after an oral biopsy
To evaluate whether the clinical evaluation of a wound healing shows a correspondence with the patient perception of the same process.
One week after an oral biopsy
Correlation between the clinical healing and patient perception
Time Frame: Three weeks after an oral biopsy
To evaluate whether the clinical evaluation of a wound healing shows a correspondence with the patient perception of the same process.
Three weeks after an oral biopsy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between OHIP-14 and VNS scale
Time Frame: Six hours after an oral biopsy
Correlation between two different tools evaluating patient perception
Six hours after an oral biopsy
Correlation between OHIP-14 and VNS scale
Time Frame: One week after an oral biopsy
Correlation between two different tools evaluating patient perception
One week after an oral biopsy
Correlation between OHIP-14 and VNS scale
Time Frame: Three weeks after an oral biopsy
Correlation between two different tools evaluating patient perception
Three weeks after an oral biopsy
Clinical variables which influence the healing and patient perception
Time Frame: Six hours after an oral biopsy
To evaluate which clinical variable (systemic or local) can modify the wound healing or the patient perception.
Six hours after an oral biopsy
Clinical variables which influence the healing and patient perception
Time Frame: One week after an oral biopsy
To evaluate which clinical variable (systemic or local) can modify the wound healing or the patient perception.
One week after an oral biopsy
Clinical variables which influence the healing and patient perception
Time Frame: Three weeks after an oral biopsy
To evaluate which clinical variable (systemic or local) can modify the wound healing or the patient perception.
Three weeks after an oral biopsy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2018

Primary Completion (Actual)

March 8, 2019

Study Completion (Actual)

December 8, 2019

Study Registration Dates

First Submitted

August 6, 2020

First Submitted That Met QC Criteria

August 13, 2020

First Posted (Actual)

August 14, 2020

Study Record Updates

Last Update Posted (Actual)

August 14, 2020

Last Update Submitted That Met QC Criteria

August 13, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OHIP-OB

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on OHIP-14 Administration

Subscribe